Medical Research
Hauptman-Woodward Medical Research Institute Inc
BUFFALO, NY
Total revenue
$11.0M
Total expenses
$10.5M
Net assets
$22.5M
Grants received
$1.9M
40 grants
EIN
160807558
Tax year
2023
Mission
Guided by its motto, CURE-OSITY, the Hauptman-Woodward Medical Research Institute (HWI) creates novel strategies and technologies to promote the understanding, prevention, and treatment of many human diseases. HWI scientists conduct basic, fundamental research that will provide for effective therapeutic approaches far into the future. Often our research includes identifying proteins involved in disease which allows treatments to be more effective by targeting those proteins. Examples of current projects include breast cancer, prostate cancer, multiple myeloma, studying the effect of gravity on cells, and biological cell structure determination for nearly all disease through the use of hard X-ray free electron lasers (XFELs) and high-throughput crystallization.
Programs
3 programs
IMCA-CAT provided an outstanding support environment for macro-molecular crystallography by developing and operating an efficient, reliable , high-throughput facility at which both confidential and proprietary equipment can be readily and easily accommodated.
The National HTX Center aims to implement a modern internet interface for users of the High-Throughput Crystallization Screening Center to interact with the images of their crystallization screening experiments. A further goal is to begin development of software to enable automatic image analysis and classification.
Other Program Services include various research work undertaken in endocrine biochemistry and molecular biophysics to develop and understand the cause of disease and potential therapies for the cure. Expenses $9,007,926 include grants of $0 and revenue of $367,718.
Financials
FY 2023
Revenue
Expenses
People
31 listed
Lisa Keefe
VP
$226K
37.5 hrs/wk
Edward Snell
Chief Scientific Officer
$156K
37.5 hrs/wk
Anne Kent
Chief Financial Officer
$153K
37.5 hrs/wk
Christopher Greene
Interim CEO
$120K
1 hrs/wk
Sarah Bowman
Board Member/Associate Investigator
$100K
37.5 hrs/wk
Venu Govindaraju
Board Member
—
0.2 hrs/wk
Andrei Gudkov
Board Member
—
0.2 hrs/wk
William Harries
Board Member
—
0.2 hrs/wk
Michele Heffernan
Board Member
—
0.2 hrs/wk
Dan Magnuszewski
Board Member
—
0.2 hrs/wk
Brenda McDuffie
Board Member
—
0.2 hrs/wk
Sean Moskal
Chairman of Finance Committee
—
0.2 hrs/wk
Philip Nobel
Board Member
—
0.2 hrs/wk
Jeffrey Renzoni
Board Member
—
0.2 hrs/wk
Nena Rich
Board Member
—
0.2 hrs/wk
Sam Russo
Board Member/Chairperson of the Board
—
0.2 hrs/wk
Franca Trincia
Board Member
—
0.2 hrs/wk
Christina Arthurs
Board Member
—
0.2 hrs/wk
LaVonne Ansari
Board Member
—
0.2 hrs/wk
Tricia Barrett
Board Member/Vice Chairperson of the Board
—
0.2 hrs/wk
Steve Bell
Board Member
—
0.2 hrs/wk
Jill Bond
Board Member/Secretary
—
0.2 hrs/wk
EJ Burke
Board Member
—
0.2 hrs/wk
William Constantine
Board Member
—
0.2 hrs/wk
Artem Evdokimov
Board Member
—
0.2 hrs/wk
Frank Ewing
Board Member
—
0.2 hrs/wk
Devrim Acehan
Cryo-EM Director
$139K
37.5 hrs/wk
Blanca Carbajal
Business Development Director
$137K
37.5 hrs/wk
Daniel Gewirth
Principal Research Scientist
$135K
37.5 hrs/wk
John Muir
Software Developer
$123K
37.5 hrs/wk
Aviv Paz
Principal Investigator
$103K
37.5 hrs/wk
Grants received
Showing 40 of 40
Funded by
$1.9M from 13 funders · 40 grants · 2017–2024
$647K · 8 grants · 2017–2023
$489K · 5 grants · 2019–2024
$335K · 2 grants · 2019–2020
$297K · 2 grants · 2022–2023
$41K · 4 grants · 2017–2023
$28K · 7 grants · 2018–2024
$20K · 4 grants · 2020–2023
$20K · 2 grants · 2021